H19 gene therapy(Cardior Pharmaceutials)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameH19 gene therapy(Cardior Pharmaceutials)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHannover Medical School
China Registration ClassN/A
Develop Information
Active CompaniesHannover Medical School
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A